Cochrane · systematic review · CD009926
Subsidising artemisinin‐based combination therapy in the private retail sector
Opiyo, N, Yamey, G, Garner, P · Cochrane Database of Systematic Reviews · 2016 · Cochrane Library
Effective Practice and Organisation of CareAMSTAR 2: not assessed
SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.
Questions
9
current version
GRADE rated
8
No studies
0
Included studies
NR
No studies 0 · 0%Ungraded 1 · 11.1%Very low 1 · 11.1%Low 0 · 0%Moderate 0 · 0%High 7 · 77.8%
Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.
Questions and results
ACT subsidies combined with supportive interventions versus no subsidies
Population: Patients seeking treatment for suspected uncomplicated malaria
| Outcome | Effect | Evidence | Status / GRADE |
|---|---|---|---|
ACT use (percentage of children under 5 years receiving ACT on the same day or following day of fever onset) ACT subsidies combined with supportive interventions vs no subsidies | no estimate extracted | 1 study · 26626 participants | High |
ACT availability (percentage of outlets stocking ACTs for children under 5 years) ACT subsidies combined with supportive interventions vs no subsidies | no estimate extracted | 1 study · 2 participants | High |
ACT availability (percentage of outlets stocking at least one ACT for patients of any age) ACT subsidies combined with supportive interventions vs no subsidies | no estimate extracted | 1 study · 1 participants | Very low Downgraded: risk of bias, indirectness |
ACT price (change in ACT prices for children under 5 years)c ACT subsidies combined with supportive interventions vs no subsidies | no estimate extracted | 1 study · 1 participants | High |
ACT market share (volume of ACTs purchased as a proportion of all antimalarials purchased; all age groups) ACT subsidies combined with supportive interventions vs no subsidies | no estimate extracted | 1 study · 2 participants | High |
Use of older antimalarials (amodiaquine, sulphadoxine‐pyrimethamine; children under 5 years) ACT subsidies combined with supportive interventions vs no subsidies | no estimate extracted | 1 study · 1 participants | High |
Adverse effects (such as the number of people receiving ACTs who do not have malaria) ACT subsidies combined with supportive interventions vs no subsidies | no estimate extracted | 3 studies · 3 participants | Ungraded |
ACT price vouchers versus no subsidies
Population: Patients seeking treatment for suspected uncomplicated malaria
| Outcome | Effect | Evidence | Status / GRADE |
|---|---|---|---|
ACT access (percentage of illness episodes treated with ACTs; all age groups) ACT price vouchers vs no subsidies | no estimate extracted | 1 study · 2789 participants | High |
ACT targeting (percentage of ACT takers who are malaria positive; all age groups) ACT price vouchers vs no subsidies | no estimate extracted | 1 study · 2789 participants | High |